Lymph Node Swelling; Fever; Chills; Fatigue; Headache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Physician). The reporter is the patient.  A 74 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 27Sep2021 12:00 (Lot number: FF2587) at the age of 74 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "High cholesterol" (unspecified if ongoing); "Benign Essential Tremor" (unspecified if ongoing); "migraine", start date: 22Sep2015 (unspecified if ongoing), notes: migraine. Concomitant medication(s) included: ATORVASTATIN; PROPRANOLOL; MONTELUKAST; NASALCROM, start date: 20Jun2018; MIRTAZAPINE; MAXALT MLT taken for migraine, start date: 22Sep2015; CALCIUM +D [CALCIUM;ERGOCALCIFEROL]; PROPRANOLOL HCL; PROLIA; PRAVASTATIN; OCUVITE [ASCORBIC ACID;RETINOL;TOCOPHEROL]. Past drug history included: Epinephrine for unknown indication, reaction(s): "heart races". Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EM9809, Location of injection: Arm Left, Vaccine Administration Time: 12:00 AM), administration date: 14Feb2021, when the patient was 74 years old; Bnt162b2 (Dose Number: 2, Batch/Lot No: EN6204, Location of injection: Arm Left, Vaccine Administration Time: 12:00 AM), administration date: 09Mar2021, when the patient was 74 years old, for COVID-19 immunisation. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 28Sep2021, outcome "recovered" (2021), described as "Lymph Node Swelling"; PYREXIA (non-serious) with onset 28Sep2021, outcome "recovered" (2021), described as "Fever"; CHILLS (non-serious) with onset 28Sep2021, outcome "recovered" (2021), described as "Chills"; FATIGUE (non-serious) with onset 28Sep2021, outcome "recovering", described as "Fatigue"; HEADACHE (non-serious) with onset 28Sep2021, outcome "recovered" (2021), described as "Headache". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of lymphadenopathy, pyrexia, chills, fatigue, headache.  Additional information included: Patient said she spent spent 8 days in bed. Patient's concomitant medications included: NasalCrom(Cromolyn Sodium) 5.2 MG/ACT Aerosol Solution, Sig: 1 puff in each nostril Nasally Three times a day as needed from 20Jun2018, Multivitamins: 1 tablet by mouth Once dally, Montelukast Sodium 10 MG Tablet, Sig: take 1 tablet by mouth every day, Mirtazapine 15 MG Tablet, Sig: take 1 tablet by mouth every day at bedtime, Maxalt-MLT(Rizatriptan Benzoate) 10 MG Tablet Disintegrating, Sig: 1/2-1 tablet on the tongue and allow to dissolve as needed one time Orally Once a day as needed for migraine Start Date: 22Sep2015, Notes: when needed, Calcium + Vitamin D3(Calcium-Vitamin D) 500-400 MG-UNIT Tablet Chewable, Sig: 1 tablet with a meal Orally Once a day, Propranolol HCI 20 MG Tablet, Sig: take 1 tablet by mouth every day, Prolia(Alpha1-Proteinase Inhibitor) 60 mg/ml Solution, Sig: 1cc SQ every 6 months 1 day, Notes: wong, Pravastatin Sodium 40 MG Tablet, Sig: take 1 tablet by mouth every day and Ocuvite- Tablet, Sig: Orally daily, Notes: otc.   No follow-up attempts are possible. No further information is expected.